Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 944 of 1,261

  1. US 8067530

    Scytovirin domain 1 related polypeptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  2. US 8067466

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

    Esperion Therapeutics, Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  3. US 8067460

    5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel

    The Regents of the University of California · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  4. US 8067453

    Neurotrophin production/secretion promoting agent

    Takeda Pharmaceutical Company Limited · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  5. US 8067431

    Chemically modified small molecules

    Nektar Therapeutics · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  6. US 8067423

    Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  7. US 8067377

    Peptide compositions for targeting adipose tissue

    The Board of Regents of the University of Texas System · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  8. US 8067390

    Therapeutic targeting of interleukins using siRNA in neutral liposomes

    The Board of Regents of the University of Texas System · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  9. US 8067030

    Controlled release composition and method of producing the same

    Takeda Pharmaceutical Company Limited · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  10. US 8067445

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  11. US 8067606

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  12. US 8063195

    Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  13. US 8062654

    Drug releasing biodegradable fiber for delivery of therapeutics

    The Board of Regents of the University of Texas System · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  14. US 8063057

    Multicyclic amino acid derivatives and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  15. US 8063047

    Pyridazine compounds and methods

    Northwestern University · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  16. US 8063066

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  17. US 8063089

    Inhibitors of nucleophosmin (NPM) and methods for inducing apoptosis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  18. US 8063209

    Phosphonyl ester conjugates as prodrugs

    The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  19. US 8063250

    Crystal forms of O-desmethylvenlafaxine fumarate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  20. US 8063211

    Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  21. US 8063248

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  22. US 8062643

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  23. US 8062647

    High concentration baclofen preparations

    The Board of Regents of the University of Texas System · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  24. US 8062640

    High affinity human antibodies to PCSK9

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.